[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619154":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":22,"responsibleParty":40,"collaborators":10,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Nantes University Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"pediatric patient with Essilor® myopia-control spectacle lenses",null,"pediatric patient with Essilor® myopia-control spectacle lenses Stellet 2.0",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Pierre Lebranchu, MD PhD","CONTACT","+33 2 53 48 28 57","pierre.lebranchu@chu-nantes.fr",{"name":19,"role":15,"phone":20,"phoneExt":10,"email":21},"Alexandra Poinas, PhD","+ 33 2 53 48 28 57","alexandra.poinas@chu-nantes.fr",[23],{"facility":24,"status":25,"city":26,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"CHU Nantes - Ophthalmology Department","RECRUITING","Nantes","44000","France","FR",{"type":31,"coordinates":32},"Point",[33,34],-1.55336,47.21725,{"lat":34,"lon":33},[37],{"name":38,"role":15,"phone":39,"phoneExt":10,"email":21},"Alexandra Poinas","+33 2 40 08 33 33",{"type":41,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100619154","pilot-study-on-the-adaptation-and-tolerance-of-essilor-myopia-control-spectacle-lenses-100619154",false,"NCT07340931","Pilot Study on the Adaptation and Tolerance of Essilor® Myopia-control Spectacle Lenses","STELLAR","Inclusion Criteria:\n\n* Patients aged 6 to 16 years with progressive myopia.\n* Spherical equivalent ≤ -0.50 D under cycloplegia and presence of at least one risk factor (age \\\u003C 10 years, progression ≥ 0.50 D\u002Fyear, axial length increase ≥ 0.2 mm\u002Fyear, high myopia ≤ -6.00 D and\u002For axial length ≥ 26 mm, both parents myopic, at least one parent highly myopic, or Asian origin).\n* Patient covered by the French social security system.\n* Patient and legal guardians providing oral non-opposition to participate in the study.\n\nExclusion Criteria:\n\n* Patients with strabismus, amblyopia, or syndromic myopia","ALL","6 Years","16 Years",{"count":53,"type":54},50,"ESTIMATED","OBSERVATIONAL","This observational pilot study aims to evaluate the adaptation and tolerance of Essilor® Stellest® myopia-control spectacle lenses in children with progressive myopia. The objective is to assess real-life compliance and comfort during lens wear, as these factors are essential for long-term therapeutic adherence and overall visual health outcomes",[58],"Myopia",[60,61,62],"myopia","visual correction","compliance","2026-06-23",{"date":65,"type":66},"2026-06-24","ACTUAL",{"date":68,"type":66},"2026-01-20",{"date":70,"type":54},"2027-01-20",{"name":5,"class":6},1]